125 related articles for article (PubMed ID: 7604141)
1. The effect of carbamazepine on the 2-hydroxylation of desipramine.
Spina E; Avenoso A; Campo GM; Caputi AP; Perucca E
Psychopharmacology (Berl); 1995 Feb; 117(4):413-6. PubMed ID: 7604141
[TBL] [Abstract][Full Text] [Related]
2. Phenobarbital induces the 2-hydroxylation of desipramine.
Spina E; Avenoso A; Campo GM; Caputi AP; Perucca E
Ther Drug Monit; 1996 Feb; 18(1):60-4. PubMed ID: 8848823
[TBL] [Abstract][Full Text] [Related]
3. Urinary desipramine hydroxylation index and steady-state plasma concentrations of imipramine and desipramine.
Spina E; Arena A; Pisani F
Ther Drug Monit; 1987 Jun; 9(2):129-33. PubMed ID: 3617150
[TBL] [Abstract][Full Text] [Related]
4. Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects.
Spina E; Pollicino AM; Avenoso A; Campo GM; Perucca E; Caputi AP
Ther Drug Monit; 1993 Jun; 15(3):243-6. PubMed ID: 8333005
[TBL] [Abstract][Full Text] [Related]
5. Desipramine pharmacokinetics in Chinese and Caucasian volunteers.
Rudorfer MV; Lane EA; Chang WH; Zhang MD; Potter WZ
Br J Clin Pharmacol; 1984 Apr; 17(4):433-40. PubMed ID: 6721989
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of desipramine 2-hydroxylation by quinidine and quinine.
Steiner E; Dumont E; Spina E; Dahlqvist R
Clin Pharmacol Ther; 1988 May; 43(5):577-81. PubMed ID: 3365919
[TBL] [Abstract][Full Text] [Related]
7. Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramine.
Brøsen K; Gram LF
Eur J Clin Pharmacol; 1989; 37(2):155-60. PubMed ID: 2792169
[TBL] [Abstract][Full Text] [Related]
8. The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma.
Cooke RG; Warsh JJ; Stancer HC; Reed KL; Persad E
Clin Pharmacol Ther; 1984 Sep; 36(3):343-9. PubMed ID: 6467794
[TBL] [Abstract][Full Text] [Related]
9. Differences in the inhibitory effect of cimetidine on desipramine metabolism between rapid and slow debrisoquin hydroxylators.
Steiner E; Spina E
Clin Pharmacol Ther; 1987 Sep; 42(3):278-82. PubMed ID: 3621781
[TBL] [Abstract][Full Text] [Related]
10. Hydroxylation of desmethylimipramine: dependence on the debrisoquin hydroxylation phenotype.
Spina E; Steiner E; Ericsson O; Sjöqvist F
Clin Pharmacol Ther; 1987 Mar; 41(3):314-9. PubMed ID: 3816019
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of desipramine hydroxylation (Cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivo.
von Moltke LL; Greenblatt DJ; Duan SX; Daily JP; Harmatz JS; Shader RI
J Pharm Sci; 1998 Oct; 87(10):1184-9. PubMed ID: 9758674
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic consistency in hydroxylation of desmethylimipramine and debrisoquine in healthy subjects and in human liver microsomes.
Spina E; Birgersson C; von Bahr C; Ericsson O; Mellström B; Steiner E; Sjöqvist F
Clin Pharmacol Ther; 1984 Nov; 36(5):677-82. PubMed ID: 6488689
[TBL] [Abstract][Full Text] [Related]
13. Active metabolites of imipramine and desipramine in man.
Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
[TBL] [Abstract][Full Text] [Related]
14. Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study.
Spina E; Gitto C; Avenoso A; Campo GM; Caputi AP; Perucca E
Eur J Clin Pharmacol; 1997; 51(5):395-8. PubMed ID: 9049581
[TBL] [Abstract][Full Text] [Related]
15. Carbamazepine metabolism in man. Induction and pharmacogenetic aspects.
Eichelbaum M; Tomson T; Tybring G; Bertilsson L
Clin Pharmacokinet; 1985; 10(1):80-90. PubMed ID: 3971637
[TBL] [Abstract][Full Text] [Related]
16. Coadministration of nefazodone and desipramine: a pharmacokinetic interaction study.
Khan AY; Preskorn SH; Horst WD
J Pak Med Assoc; 2007 May; 57(5):230-5. PubMed ID: 17571477
[TBL] [Abstract][Full Text] [Related]
17. Different effects of desipramine on bufuralol 1''-hydroxylation by rat and human CYP2D enzymes.
Isobe T; Hichiya H; Hanioka N; Yamamoto S; Shinoda S; Funae Y; Satoh T; Yamano S; Narimatsu S
Biol Pharm Bull; 2005 Apr; 28(4):634-40. PubMed ID: 15802801
[TBL] [Abstract][Full Text] [Related]
18. Desipramine hydroxylation: variability and effect of antipsychotic drugs.
Bock JL; Nelson JC; Gray S; Jatlow PI
Clin Pharmacol Ther; 1983 Mar; 33(3):322-8. PubMed ID: 6130865
[TBL] [Abstract][Full Text] [Related]
19. Desmethylimipramine overdose: nonlinear kinetics in a slow hydroxylator.
Spina E; Henthorn TK; Eleborg L; Nordin C; Säwe J
Ther Drug Monit; 1985; 7(2):239-41. PubMed ID: 4024220
[TBL] [Abstract][Full Text] [Related]
20. Effects of desvenlafaxine on the pharmacokinetics of desipramine in healthy adults.
Nichols AI; Abell M; Chen Y; Behrle JA; Frick G; Paul J
Int Clin Psychopharmacol; 2013 Mar; 28(2):99-105. PubMed ID: 23221858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]